Yuhao He

Yuhao He

Auto-generated profile, based on publicly available information

Yuhao He

Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong, P.R. China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
Liang FangLiang Fang
Liang Fang
LZLi Zhang
Li Zhang
MWMengran Wang
Mengran Wang
YHYuhao He
Yuhao He
JYJiao Yang
Jiao Yang
WCWei Chen
Wei Chen
Epithelial–mesenchymal transition (EMT) is a fundamental cellular process frequently hijacked by cancer cells to promote tumor progression, especially metastasis. EMT is orchestrated by a complex molecular network acting at different layers of gene regulation. In addition to transcriptional regulation, posttranscriptional mechanisms may also play a role in EMT. Here, we performed a pooled CRISPR screen analyzing the influence of 1,547 RNA-binding proteins on cell motility in colon cancer cells and identified multiple core components of P-bodies (PB) as negative modulators of cancer cell migration. Further experiments demonstrated that PB depletion by silencing DDX6 or EDC4 could activate hallmarks of EMT thereby enhancing cell migration in vitro as well as metastasis formation in vivo. Integrative multiomics analysis revealed that PBs could repress the translation of the EMT driver gene HMGA2, which contributed to PB-meditated regulation of EMT. This mechanism is conserved in other cancer types. Furthermore, endoplasmic reticulum stress was an intrinsic signal that induced PB disassembly and translational derepression of HMGA2. Taken together, this study has identified a function of PBs in the regulation of EMT in cancer. Significance: Systematic investigation of the influence of posttranscriptional regulation on cancer cell motility established a connection between P-body–mediated translational control and EMT, which could be therapeutically exploited to attenuate metastasis formation.

4 March 2024
Verified
Other
Open access
Liang FangLiang Fang
Liang Fang
LZLi Zhang
Li Zhang
MWMengran Wang
Mengran Wang
YHYuhao He
Yuhao He
JYJiao Yang
Jiao Yang
WCWei Chen
Wei Chen
Table S4. The list of differentially expressed genes upon DDX6 or EDC4 knockout

4 March 2024
Verified
Other
Open access
Liang FangLiang Fang
Liang Fang
LZLi Zhang
Li Zhang
MWMengran Wang
Mengran Wang
YHYuhao He
Yuhao He
JYJiao Yang
Jiao Yang
WCWei Chen
Wei Chen
Table S3. The list of candidate genes

4 March 2024
Verified
Other
Open access
Liang FangLiang Fang
Liang Fang
LZLi Zhang
Li Zhang
MWMengran Wang
Mengran Wang
YHYuhao He
Yuhao He
JYJiao Yang
Jiao Yang
WCWei Chen
Wei Chen
Table S5. The list of peaks and genes enriched in DDX6-eCLIP-seq

4 March 2024
Verified
Other
Open access
Liang FangLiang Fang
Liang Fang
LZLi Zhang
Li Zhang
MWMengran Wang
Mengran Wang
YHYuhao He
Yuhao He
JYJiao Yang
Jiao Yang
WCWei Chen
Wei Chen
Epithelial–mesenchymal transition (EMT) is a fundamental cellular process frequently hijacked by cancer cells to promote tumor progression, especially metastasis. EMT is orchestrated by a complex molecular network acting at different layers of gene regulation. In addition to transcriptional regulation, posttranscriptional mechanisms may also play a role in EMT. Here, we performed a pooled CRISPR screen analyzing the influence of 1,547 RNA-binding proteins on cell motility in colon cancer cells and identified multiple core components of P-bodies (PB) as negative modulators of cancer cell migration. Further experiments demonstrated that PB depletion by silencing DDX6 or EDC4 could activate hallmarks of EMT thereby enhancing cell migration in vitro as well as metastasis formation in vivo. Integrative multiomics analysis revealed that PBs could repress the translation of the EMT driver gene HMGA2, which contributed to PB-meditated regulation of EMT. This mechanism is conserved in other cancer types. Furthermore, endoplasmic reticulum stress was an intrinsic signal that induced PB disassembly and translational derepression of HMGA2. Taken together, this study has identified a function of PBs in the regulation of EMT in cancer.Significance:Systematic investigation of the influence of posttranscriptional regulation on cancer cell motility established a connection between P-body–mediated translational control and EMT, which could be therapeutically exploited to attenuate metastasis formation.

4 March 2024
Verified
Other
Open access
Liang FangLiang Fang
Liang Fang
LZLi Zhang
Li Zhang
MWMengran Wang
Mengran Wang
YHYuhao He
Yuhao He
JYJiao Yang
Jiao Yang
WCWei Chen
Wei Chen
Epithelial–mesenchymal transition (EMT) is a fundamental cellular process frequently hijacked by cancer cells to promote tumor progression, especially metastasis. EMT is orchestrated by a complex molecular network acting at different layers of gene regulation. In addition to transcriptional regulation, posttranscriptional mechanisms may also play a role in EMT. Here, we performed a pooled CRISPR screen analyzing the influence of 1,547 RNA-binding proteins on cell motility in colon cancer cells and identified multiple core components of P-bodies (PB) as negative modulators of cancer cell migration. Further experiments demonstrated that PB depletion by silencing DDX6 or EDC4 could activate hallmarks of EMT thereby enhancing cell migration in vitro as well as metastasis formation in vivo. Integrative multiomics analysis revealed that PBs could repress the translation of the EMT driver gene HMGA2, which contributed to PB-meditated regulation of EMT. This mechanism is conserved in other cancer types. Furthermore, endoplasmic reticulum stress was an intrinsic signal that induced PB disassembly and translational derepression of HMGA2. Taken together, this study has identified a function of PBs in the regulation of EMT in cancer.Significance:Systematic investigation of the influence of posttranscriptional regulation on cancer cell motility established a connection between P-body–mediated translational control and EMT, which could be therapeutically exploited to attenuate metastasis formation.